This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): azithromycin extended release oral suspension, azithromycin SR
Description: Zmax is an extended release formulation of Zithromax. Zmax is given as a single, one-time 2 gram dose.
The active ingredient, azithromycin, is an azalide, a subclass of macrolide antibiotics. It exerts its antimicrobial effects by binding to bacterial 50S ribosomal subunit, thus blocking bacterial protein synthesis.
Pink Sheet ‘Complete Response’ Letters
Additional information available to subscribers only: